49 |
Therapeutic Angiogenesis for Peripheral Arterial Occlusive Disease |
Duk-Kyung Kim |
Jan. 21. 05 |
48 |
Mobilizing Stem Cells to Treat Acute Myocardial Infarction: First Results from the RECOVER Pilot |
Stephen G. Ellis |
Jan. 21. 05 |
47 |
Heterogeneity of Endothelial Progenitor Cells and Synergism between? Two Types of EPCs |
Hyo-Soo Kim |
Jan. 21. 05 |
46 |
The Value of Animal Models in Evaluating Pathobiologic Effects of Drug-Eluting Stents: Insights from Past Successes and Failures |
Renu Virmani |
Jan. 14. 05 |
45 |
The Whole Truth on Incomplete Apposition with DES: Observations from Studies with Silolimus, Paclitaxel and Beyond |
Gary S. Mintz |
Jan. 14. 05 |
44 |
PPAR-r Agonist and In-stent Restenosis |
Yangsoo Jang |
Jan. 14. 05 |
43 |
FIM Results with a PC-coated Angiopeptin-Eluting Stent: Angiographic and IVUS Results |
Vincent On-Hing Kwok |
Jan. 14. 05 |
42 |
Drug-Eluting Stenting: Update on ABT 578(PREFER, and ENDEAVOR-I) |
Ian T. Meredith |
Jan. 07. 05 |
41 |
New Drug-Eluting Stent Trials: EASTER, IMPACT, PISCES, BioRest, and More |
Alexandre Abizaid |
Jan. 07. 05 |
40 |
Long Cypher Multicenter Registry Study |
Seung-Jung Park |
Jan. 07. 05 |